Freeline Therapeutics Holdings plc Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Freeline Therapeutics Holdings plc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2022.
  • Freeline Therapeutics Holdings plc Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $973K, a 29.3% decline year-over-year.
  • Freeline Therapeutics Holdings plc annual Share-based Payment Arrangement, Expense for 2022 was $5.08M, a 52.7% decline from 2021.
  • Freeline Therapeutics Holdings plc annual Share-based Payment Arrangement, Expense for 2021 was $10.7M, a 72.8% increase from 2020.
  • Freeline Therapeutics Holdings plc annual Share-based Payment Arrangement, Expense for 2020 was $6.2M, a 325% increase from 2019.
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $5.08M -$5.65M -52.7% Jan 1, 2022 Dec 31, 2022 20-F 2023-04-04
2021 $10.7M +$4.52M +72.8% Jan 1, 2021 Dec 31, 2021 20-F 2023-04-04
2020 $6.2M +$4.75M +325% Jan 1, 2020 Dec 31, 2020 20-F 2023-04-04
2019 $1.46M +$1.35M +1180% Jan 1, 2019 Dec 31, 2019 20-F 2022-03-31
2018 $114K Jan 1, 2018 Dec 31, 2018 20-F 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.